| Literature DB >> 15246899 |
Rainer Hoffmann1, Roswitha Langenberg, Peter Radke, Andreas Franke, Rüdiger Blindt, Jan Ortlepp, Jeff J Popma, Christian Weber, Peter Hanrath.
Abstract
This study evaluated the safety and efficacy of a dexamethasone-eluting stent with a special high dexamethasone-loading dose for treatment of de novo coronary lesions in 30 patients. Eight patients had in-stent restenosis (restenosis rate 31%) at 6-month follow-up, and the in-stent late lumen loss was 0.96 +/- 0.63 mm due to an average intimal hyperplasia area obstruction of 32 +/- 21%, indicating that high-dose dexamethasone-loaded stents do not significantly reduce neointimal proliferation.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15246899 DOI： 10.1016/j.amjcard.2004.03.061
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778